The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 668.10
Bid: 667.90
Ask: 668.10
Change: 4.50 (0.68%)
Spread: 0.20 (0.03%)
Open: 666.40
High: 670.80
Low: 666.40
Prev. Close: 663.60
HSBA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of the sale of HSBC Bank Canada to RBC

2 Apr 2024 07:00

RNS Number : 8207I
HSBC Holdings PLC
29 March 2024
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

 

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this document, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this document.

 

 

 

29 March 2024

(Hong Kong Stock Code: 5)

 

HSBC HOLDINGS PLC

Completion of the sale of HSBC Bank Canada to RBC

 

HSBC Holdings plc ('HSBC') completed the sale of HSBC Bank Canada ('HSBC Canada') and its subsidiaries to Royal Bank of Canada ('RBC') on 28 March 2024.

 

The sale followed a strategic review of HSBC Canada which concluded the best course of action strategically for the HSBC Group and HSBC Canada was to sell the business. The transaction unlocks significant value for the HSBC Group.

 

Commenting on the transaction, Noel Quinn, Group CEO said, "I am grateful to the team in Canada for their hard work over the last 18 months delivering this transaction. This is a great business with exceptional people and clients, and I have no doubt it will thrive as part of RBC. Completing this deal is another important milestone in HSBC's transformation, and it will provide capital that will enable us to grow our core businesses and reward our shareholders for their loyalty, including through an intended special dividend of US$0.21 per share."

 

Completion of the transaction will result in the recognition of an estimated gain on sale of US$4.9bn in the first quarter of 2024, inclusive of the recycling of an estimated US$0.6bn in foreign currency translation reserve losses1. There is no tax on the estimated gain recognised at completion. As a consequence of the gain on sale, the disposal of HSBC Canada RWAs and the recognition of the special dividend, the HSBC Group's CET1 ratio will be enhanced by an estimated 0.7 percentage points2.

 

Subject to finalisation of its results for the first quarter of 2024 ('1Q24') and consideration and approval by the Board, HSBC intends to announce a special dividend of US$0.21 per share together with its 1Q24 earnings release expected to be published on 30 April 2024. This would be in addition to any proposed interim dividend to be considered by the Board and would be expected to be paid at the same time in June 2024 if approved.

For and on behalf of

HSBC Holdings plc

 

 

Aileen Taylor

Group Company Secretary and Chief Governance Officer

 

 

1 Estimates are as at 22 March 2024, and exclude fair value gains or losses on related foreign exchange hedges to be recognised in the quarter.

2 Based on HSBC Group RWAs of US$854bn and HSBC Canada RWAs on a PRA basis (excluding operational risk RWAs) of US$28bn as at 31 December 2023. The estimated CET1 ratio impact includes the impact of a US$0.21 per share special dividend, and excludes impacts on foreign currency-related RWAs at the HSBC Group level. The favourable CET1 impact arising from the disposal of HSBC Canada RWAs, reduced by the impact of a foreseeable US$0.21 per share special dividend will be recognised in the first quarter of 2024. The favourable impact arising from the recognition of the gain on sale will be recognised upon the verification of interim profits during the second quarter of 2024.

 

 

 

 

Miscellaneous

 

The Board of Directors of HSBC Holdings plc as at the date of this announcement comprises:

Mark Edward Tucker*, Noel Paul Quinn, Geraldine Joyce Buckingham†, Rachel Duan†, Georges Bahjat Elhedery, Dame Carolyn Julie Fairbairn†, James Anthony Forese†, Ann Frances Godbehere†, Steven Craig Guggenheimer†, Dr José Antonio Meade Kuribreña†, Kalpana Jaisingh Morparia†, Eileen K Murray†, Brendan Robert Nelson†, David Thomas Nish† and Swee Lian Teo†.

 

*  Non-executive Group Chairman

  Independent non-executive Director

 

 

This announcement contains both historical and forward-looking statements. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Forward-looking statements may be identified by the use of terms such as 'expects,' 'targets,' 'believes,' 'seeks,' 'estimates,' 'may,' 'intends,' 'plan,' 'will,' 'should,' 'potential,' 'reasonably possible', 'anticipates,' 'project', or 'continue', variation of these words, the negative thereof or similar expressions or comparable terminology. HSBC has based the forward-looking statements on current plans, information, data, estimates, expectations and projections about, among other things, results of operations, financial condition, prospects, strategies and future events, and therefore undue reliance should not be placed on them. These forward-looking statements are subject to risks, uncertainties and assumptions about us, as described under 'Cautionary statement regarding forward-looking statements' contained in the HSBC Holdings plc Annual Report on Form 20-F for the year ended 31 December 2023, filed with the SEC on 22 February 2024 (the '2023 Form 20-F'). HSBC undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In light of these risks, uncertainties and assumptions, the forward-looking events discussed herein might not occur. Investors are cautioned not to place undue reliance on any forward-looking statements, which speak only as of their dates. No representation or warranty is made as to the achievement or reasonableness of and no reliance should be placed on such forward-looking statements. Additional information, including information on factors which may affect the HSBC Group's business, is contained in the 2023 Form 20-F.

 

ends/more

 

Investor enquiries to:

Neil Sankoff +44 (0) 20 7991 5072 investorrelations@hsbc.com

Yafei Tian +852 2899 8909 yafei.tian@hsbc.com.hk

 

Media enquiries to:

HSBC press office +44 (0) 20 79918096 pressoffice@hsbc.com

 

 

Note to editors:

HSBC Holdings plc, the parent company of the HSBC, is headquartered in London. HSBC serves customers worldwide from offices in 62 countries and territories. With assets of US$3,039bn at 31 December 2023, HSBC is one of the world's largest banking and financial services organisations.

 

 

 

HSBC Holdings plc

Registered Office and Group Head Office:

8 Canada Square, London E14 5HQ, United Kingdom

Web: www.hsbc.com

Incorporated in England with limited liability. Registered in England: number 617987

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISGXGDXCUDDGSC
Date   Source Headline
29th Apr 20244:30 pmRNSTotal Voting Rights
29th Apr 20244:15 pmRNSDirector/PDMR Shareholding
23rd Apr 20246:04 pmRNSTransaction in Own Shares & Conclusion of Buy-Back
22nd Apr 20245:59 pmRNSTransaction in Own Shares
19th Apr 20245:57 pmRNSTransaction in Own Shares
19th Apr 20248:40 amRNSPost Stabilisation Notice
18th Apr 20245:58 pmRNSTransaction in Own Shares
18th Apr 202410:00 amRNSOverseas Regulatory Announcement - Board Meeting
17th Apr 20246:15 pmRNSTransaction in Own Shares
16th Apr 20246:00 pmRNSTransaction in Own Shares
15th Apr 20246:24 pmRNSTransaction in Own Shares
15th Apr 20241:00 pmRNSFourth Interim Dividend for 2023 - Exchange Rate
12th Apr 20245:57 pmRNSTransaction in Own Shares
12th Apr 20243:35 pmRNSNotice of redemption
11th Apr 20246:25 pmRNSTransaction in Own Shares
11th Apr 202410:00 amRNSOverseas Regulatory Announcement - Grant of Awards
10th Apr 20246:09 pmRNSTransaction in Own Shares
9th Apr 20245:53 pmRNSTransaction in Own Shares
9th Apr 20247:00 amRNSHSBC AGREES TO SELL ITS BUSINESS IN ARGENTINA
8th Apr 20246:10 pmRNSTransaction in Own Shares
5th Apr 202410:00 amRNSDirector Declaration
4th Apr 20246:24 pmRNSTransaction in Own Shares
3rd Apr 20246:14 pmRNSTransaction in Own Shares
2nd Apr 20245:59 pmRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSCompletion of the sale of HSBC Bank Canada to RBC
28th Mar 20246:01 pmRNSTransaction in Own Shares
28th Mar 20244:30 pmRNSDirector/PDMR Shareholding
28th Mar 20244:00 pmRNSTotal Voting Rights
27th Mar 20245:58 pmRNSTransaction in Own Shares
27th Mar 20243:45 pmRNSPublication of base prospectus
26th Mar 20245:54 pmRNSTransaction in Own Shares
25th Mar 20245:58 pmRNSTransaction in Own Shares
22nd Mar 20245:50 pmRNSTransaction in Own Shares
22nd Mar 20242:00 pmRNSIssuance of subordinated unsecured notes
22nd Mar 202410:00 amRNS2024 AGM - Documents available at NSM
21st Mar 20246:03 pmRNSTransaction in Own Shares
21st Mar 202411:00 amRNSIssuance of subordinated unsecured notes
20th Mar 20245:51 pmRNSTransaction in Own Shares
20th Mar 202410:00 amRNSHong Kong Waiver-Contingent Convertible Securities
19th Mar 20245:46 pmRNSTransaction in Own Shares
19th Mar 202410:00 amRNSOverseas Regulatory Announcement - Grant of Awards
18th Mar 20245:54 pmRNSTransaction in Own Shares
18th Mar 202411:20 amRNSPre Stabilisation Notice
15th Mar 20246:20 pmRNSTransaction in Own Shares
14th Mar 20246:07 pmRNSTransaction in Own Shares
14th Mar 20245:02 pmRNSDirector/PDMR Shareholding
13th Mar 20246:20 pmRNSTransaction in Own Shares
13th Mar 20244:00 pmRNSDirector/PDMR Shareholding
12th Mar 20246:06 pmRNSTransaction in Own Shares
12th Mar 202411:00 amRNSIssuance of subordinated unsecured notes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.